Labshake search
Citations for R&D Systems :
51 - 100 of 128 citations for Clostridium Difficile Toxoid B since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: ... We established in vitro quantification of granzyme B (antibody sets from R&D Systems) and perforin (antibody sets from MABTECH) ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Immunology 2021Quote: ... and goat anti-Granzyme B ab (R&D systems, AF1865, at 1:50 dilution) in above blocking solution overnight at +40C ...
-
bioRxiv - Molecular Biology 2019Quote: ... contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat. # B-20), protease inhibitor cocktail ...
-
bioRxiv - Molecular Biology 2019Quote: ... contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat. # B-20), protease inhibitor cocktail ...
-
bioRxiv - Cell Biology 2020Quote: ... and were treated with 10 ng/mL TGF-β1 (R&D systems, 240-B) or IMRC conditioned medium where specified ...
-
bioRxiv - Cancer Biology 2021Quote: ... and b) Goat anti-human CD4 (1:400, R&D Systems AF-379-NA) and Rabbit anti-human CD8 (1:400 ...
-
bioRxiv - Immunology 2022Quote: ... SARS-CoV-2 B.1.1.529 S GCN4-IZ-2P (11061-CV, R&D Systems), MERS-CoV S GCN4-IZ-2P (R&D Systems) ...
-
bioRxiv - Cancer Biology 2023Quote: ... and granzyme B DuoSet ELISA kits were purchased from R&D Systems (Minneapolis, MN). OVA 257-264 (SIINFEKL peptides) ...
-
bioRxiv - Cell Biology 2023Quote: ... Anti-Cathepsin B (goat polyclonal; 1:200 IF; R&D Systems AF965; RRID: AB_2086949), Anti-Cathepsin D (goat polyclonal ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL human basic fibroblast growth factor (b-FGF) (R&D Systems, Inc.), and 10 μM Y27632 (FUJIFILM Wako Pure Chemical Corporation ...
-
bioRxiv - Neuroscience 2023Quote: ... mouse anti Creatine Kinase B (dilution 1:5000, cat no MAB9076, R&D Systems), rabbit anti HA (dilution 1:2000 ...
-
bioRxiv - Physiology 2020Quote: ... B-cells were stained using rat anti-B220/CD45R antibodies (R&D systems, Cat# MAB1217)
-
bioRxiv - Bioengineering 2020Quote: ... and granzyme B DuoSet ELISA kits were purchased from R&D Systems (Minneapolis, MN, USA). Carboxyfluorescein succinimidyl ester (CFSE) ...
-
bioRxiv - Immunology 2022Quote: ... Primary B cell complete media also contains 5 ng/ml of BAFF (R&D Systems).
-
bioRxiv - Developmental Biology 2019Quote: ... biotinylated anti-neuron-specific b-III Tubulin from R&D Systems (Clone TuJ-1, BAM1195), and Cy3-conjugated anti-smooth muscle actin (SMA ...
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 5 ng/mL recombinant human TGFβ1 (R&D Systems, 240-B) prepared according to the manufacture’s specifications ...
-
bioRxiv - Cell Biology 2023Quote: ... all the wells were treated with TGFb1 (R&D systems, #240-B-010, 5ng/ml). Drugs were used at a concentration of 10µM ...
-
bioRxiv - Bioengineering 2020Quote: ... Mouse IL-28 A/B (IFN-lambda 2/3) Du-oSet ELISA (DY1789B, R&D Systems), was used to assess cross-reactivity.
-
bioRxiv - Developmental Biology 2019Quote: ... or DMEM+10% FBS+10 ng/mL TGFβ1 (Cat. # 240-B, R&D Systems, Minneapolis, MN). A P200 tip was used scratch down the midline of every well ...
-
bioRxiv - Cell Biology 2023Quote: ... cells were treated with or without 10 ng/ml TGFβ (R&D Systems, Cat. # 240-B) for another 24 hr and harvested for RNA extraction after 72 hr.
-
bioRxiv - Bioengineering 2023Quote: ... B cell activating medium was supplemented with 5 ug/mL anti-CD40 antibody (R&D systems) and 20 ng/mL IL-4 (R&D Systems ...
-
bioRxiv - Cell Biology 2023Quote: ... starved overnight and exposed to 1.5 ng/ml of TFGβ (#100-B-001, R&D Systems) for 6 and 24 hours ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... stimulation with transforming growth factor β (TGF-β, 240-B, R&D Systems, Minneapolis, MN, USA), dissolved in 0.1% (weight/volume [w/v] ...
-
bioRxiv - Developmental Biology 2020Quote: ... or Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3) was placed in the upper and lower chambers ...
-
bioRxiv - Physiology 2019Quote: ... fully differentiated mouse or human brown adipocytes were incubated with 100ng/ml activin B (R&D Systems) in DMEM/F12 supplemented with 10% FBS and 100µg/ml penicillin-streptomycin for 24h before lysis and for RNA extraction of RNA (as indicated below) ...
-
bioRxiv - Microbiology 2020Quote: ... stimulated B cells were incubated with 20μg/ml anti–DC-SIGN mAb (clone 120507, R&D system) or mouse IgG (R & D Systems ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant TGF-β1 (#240-B-002) and human growth hormone Genotropin (Pfizer) procured from R&D Systems.
-
bioRxiv - Molecular Biology 2022Quote: ... Human TGF-β1 (240-B) and IL-1β (201-LB-005) were purchased from R&D systems.
-
bioRxiv - Cancer Biology 2023Quote: ... Inhibitors used in the study are Recombinant Human TGF-β1 protein (R&D Systems, 240-B-002), SAHA (Sigma ...
-
bioRxiv - Genetics 2023Quote: ... and receptor activator of nuclear factor kappa-B ligand (RANKL) (2 ng/mL; R&D systems; USA) to induce osteoclastogenesis ...
-
bioRxiv - Cell Biology 2023Quote: ... TGF-β pathway was stimulated by adding rhTGF-β1 ligand (2ng/mL; R&D Systems; 240-B) for 24 hours ...
-
An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangiomabioRxiv - Molecular Biology 2024Quote: ... The medium was replaced with fresh differentiation medium containing 10 ng/mL VEGF-B (R&D Systems) every two days ...
-
bioRxiv - Immunology 2022Quote: ... either alone or in combination with 1 μg/ml mouse IgG2 B anti-human TIGIT (R&D systems) or 1 μg/ml goat IgG anti-human TIM-3 (R&D systems ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
bioRxiv - Cell Biology 2020Quote: ... to RAW264.7 or 2 ng/mL transforming growth factor β-1(240-B/CF, R&D System, USA) to THP-1 for 24-36 hours ...
-
bioRxiv - Cancer Biology 2023Quote: ... granzyme B and IFN-γ secretion were measured using ELISA as described by the manufacturer (R&D Systems).
-
bioRxiv - Cell Biology 2023Quote: ... the cells were stimulated with 2 ng/mL recombinant human TGF-β1 (R&D Systems, cat. # 240-B) diluted in starvation medium for varying durations of 30 ...
-
bioRxiv - Bioengineering 2020Quote: ... 97 µL of urine was incubated with 1 µL of human cathepsin B (R&D Systems, 953-CY-010) and 1 µL of DTT for 15 minutes to inactivate the urine cysteine protease inhibitor ...
-
bioRxiv - Systems Biology 2020Quote: ... culture medium was replaced with fresh medium supplemented with 4.0 ng/ml TGF-β (R&D Systems 240-B) for 1-3 days to induce EMT ...
-
bioRxiv - Immunology 2020Quote: Primary murine B cells were incubated in 20 mM β-lactose or 0.1 μM recombinant Gal9 (R&D systems) in RPMI1640 at 37°C for 30 minutes ...
-
bioRxiv - Cancer Biology 2023Quote: ... The supernatants of these samples were subjected to Granzyme B secretion analysis using an ELISA kit (R&D Systems). Following detection of the activated cell populations in certain samples ...
-
bioRxiv - Immunology 2022Quote: ... activated B cells were washed and cultured at 0.5.106 cells/ml with 50 U/ml IL-2 (R&D Systems), 5 ng/ml IL-4 (R&D Systems ...
-
bioRxiv - Molecular Biology 2019Quote: 10 μl in vitro ubiquitylation assay reactions in 1 x ubiquitin conjugation reaction buffer (R&D systems Cat. # B-70) contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat ...
-
bioRxiv - Molecular Biology 2019Quote: 10 μl in vitro SUMOylation assay reaction in 1 x SUMO conjugation reaction buffer (R&D systems Cat. # B-60) contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat ...
-
bioRxiv - Immunology 2022Quote: ... recombinant SARS-CoV-2 Spike RBD and recombinant SARS-CoV-2 Spike RBD B.1.617.2 L452R T478K were purchased from R&D systems. Proteins were reconstituted as per the manufacturer’s instructions.
-
bioRxiv - Developmental Biology 2020Quote: ... and the combination treatment of Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3). At Day2 ...
-
bioRxiv - Cell Biology 2021Quote: Isolated cardiac fibroblasts at Passage (P)2 were treated with 10 ng/mL TGF-β1 (R&D Systems Cat #240-B) in Fibroblast Growth Medium 3 for four days to assess myofibroblast differentiation ...
-
PVT1, a YAP1 dependent stress responsive lncRNA drives ovarian cancer metastasis and chemoresistancebioRxiv - Cancer Biology 2022Quote: ... epithelial to mesenchymal transition (EMT) was induced with 200 pM of Human recombinant TGF-beta 1 (R&D Systems, 240-B); verteporfin (Sigma Aldrich ...
-
bioRxiv - Pathology 2022Quote: Antibody responses were measured against recombinant beta-SARS-CoV-2 B.1.351 spike protein (S) and its receptor binding domain (RBD) (10777-CV and 10735-CV, R&D Systems) by ELISA as previously described [23] ...